News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Erika Hamilton: Takeaways from Reshma Mahtani Updates in Early Stage HR+ BC
Erika Hamilton and Reshma Mahtani
Jul 20, 2025, 11:27

Erika Hamilton: Takeaways from Reshma Mahtani Updates in Early Stage HR+ BC

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon Research Institute, shared a post on LinkedIn:

“Reshma Mahtani updates us at NOSCM New Orleans Summer Cancer Meeting in early stage HR+ BC.

Takeaways:

  • Many are now spared chemotherapy
  • Don’t underestimate the benefit of ovarian suppression therapy
  • CDK4/6i therapy is an additional tool for higher risk patients

Edgardo S. Santos, MD, FACP, FASCO”

Reshma Mahtani

More posts featuring Erika Hamilton on OncoDaily.

Breast Cancer cancer Early Stage HR+ BC Erika Hamilton NOSCM OncoDaily Oncology Reshma Mahtani
Special Coverage
Blog
Jul 20, 2025, 11:27
Mustafa Saleh: Discussing Intra Tumoral Viral Signature Association with RCC Immune Phenotypes at KRCS25
Blog
Jul 20, 2025, 11:27
Erika Hamilton: Takeaways from Reshma Mahtani Updates in Early Stage HR+ BC
Blog
Jul 20, 2025, 11:17
Petros Grivas: Way to Go to Help Us Conquer Cancer!
Blog
Jul 20, 2025, 10:28
ALK Positive Awarded Colin Barton with Spirit of Courage Award
Radiotherapy
Jul 20, 2025, 10:28
Understanding the Role of Radiation Therapists
Oncolibrary
Jul 20, 2025, 10:24
How Aging Populations Are Reshaping Global Cancer Trends or The Silent Shift
Blog
Jul 20, 2025, 10:17
Rahul Bhargava: New Era in Myeloid Malignancy Diagnostics
Science
Jul 20, 2025, 10:08
Myeloma Paper of the Day, July 20th, Suggested by Robert Orlowski
Insight
Jul 20, 2025, 09:30
ASCO 2026 Presidential Theme: Dr. Eric Small’s Vision to Translate Science Into Global Cancer Impact
Blog
Jul 20, 2025, 09:20
Nihar Desai: How GvHD Prophylaxis Influences The Risk of Second Primary Malignancies After Allogeneic Transplants
Blog
Jul 20, 2025, 09:16
Jordan Johnson: Bringing the Experts Together is Imperative
Science
Jul 20, 2025, 09:09
Patrick Hwu: Can We Improve Immunotherapy for Hard-To-Treat Pediatric Cancers Like Rhabdomyosarcoma?